 |
 |
Piramal buys US-based Minrad to strengthen its position in anesthetics
24 December 2008
|
|
|
|
Piramal Healthcare and Pierre Fabre launch French dermo cosmetic range in India
23 July 2008
|
|
|
Piramal Healthcare acquires PlasmaSelect's polygeline product Haemaccel
03 July 2008
|
| | |
|
|
Nicholas Piramal buys two Khandelwal Laboratories brands for Rs116 crore
16 April 2008
|
|
|
Nicholas Piramal renamed Piramal Healthcare in group-wide rebranding exercise
11 March 2008
|
|
|
Nicholas Piramal Research in India's first public-private drug research project
22 February 2008
|
|
|
Nicholas Piramal R&D arm in $110-million new drug deal with Eli Lilly
15 February 2008
|
|
|
Nicholas Piramal launches hypertension product
07 February 2008
|
|
|
Nicholas Piramal buys Healthline's pharmaceuticals business
23 January 2008
|
|
|
Nicolas Piramal subsidiary Wellspring ties up with Hiranandani Hospitals
15 January 2008
|
|
|
Nicholas Piramal in JV with Japan's Arkray to market blood glucose monitoring products
19 December 2007
|
|
|
Nicholas Piramal's cyclin-dependent kinase inhibitors granted US product patent
11 December 2007
|
|
|
Nicholas Piramal in R&D collaboration with Merck & Co
19 November 2007
|
|
|
Nicholas
Piramal to de-merge its new chemical entity research unit
31 August 2007
|
|
|
Nicholas Piramal''s new
drug IND-P276 approved by US FDA
25 July 2007
|
|
|
Nicholas
Piramal in tie-up for cancer, diabetes research
11 June 2007
|
|
|
Nicholas Piramal''s Wellspring acquires majority stake in Jankharia Imaging
05 January 2007
|
|
|
Nicholas Piramal signs R&D licensing agreements with UK''s Morvus Technology
27 October 2006
|
|
|
Nicholas Piramal acquires Boots Piramal Healthcare
03 October 2006
|
|
|
Nicholas Piramal to acquire Pfizer''s UK Facility
15 June 2006
|
|
|
Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement
24 November 2005
|
|
|
AstraZeneca and Nicholas Piramal sign ''development and know-how'' agreement
27 October 2005
|
|
|
Nicholas Piramal acquires UK''s Avecia for £9.5 million
27 October 2005
|
|
|
Nicholas Piramal signs
seven alliances
19 February 2005
|
|
|
Nicholas Piramal to take over UK''s Rhodia
18 December 2004
|
|
|
Nicholas Piramal finalises product in-licensing agreement with Ethypharm, France
18 August 2004
|
|
|
Nicholas Piramal in research collaboration with National Institute of Immunology
12 August 2004
|
|
|
Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market
11 August 2004
|
|
|
Maneesh Nerurkar joins Nicholas Piramal as head of Formulations Research
31 March 2004
|
|
|
Nicholas Piramal, Indian Institute of Science to develop anti-fungal drugs
31 March 2004
|
|
|
Nicholas Piramal expands its Clinical Research facility
24 March 2004
|
|
|
World-renowned bioscientist, Dr. Saran Narang joins Nicholas Piramal Scientific Advisory Board
04 March 2004
|
|
|
Nicholas Piramal merges Canere Actives and Fine Chemicals Pvt. Ltd.
07 February 2004
|
|
|
Nicholas Piramal Q3 growth up 76.1 per cent
07 February 2004
|
|
|
Nicholas Piramal, SPPL debt programmes reaffirmed A1+
06 January 2004
|
|
|
Nicholas Piramal buys partner''s 50% stake in Sarabhai Piramal
26 December 2003
|
|
|
Nicholas Piramal enters into alliance with Biogen Idec, USA
02 December 2003
|
|
|
Nicholas Piramal follows MNC pharma companies'' strategy
03 October 2003
|
|
|
Nicholas Piramal rolls out growth plan; Maini, Chaudhuri on board
03 October 2003
|
|
|
FIIs,
banks up holdings in Ranbaxy, Dr Reddy''s, Nicholas Piramal,
Cipla
21 July 2003
|
|
|
GlaxoSmithKline
announces a dividend of Rs 7 per equity share
13 March 2003
|
|
|
GlaxoSmithKline declares second interim dividend of 37%
21 December 2002
|
|
|
Glaxo
SmithKline defers merger with Burroughs Wellcome
09 December 2002
|
|
|
Nicholas
Piramal hikes its stake in JV by 9%
09 September 2002
|
|
|
Glaxo
SmithKline to sue
Novartis, Ranbaxy
23 August 2002
|
|
|
GlaxoSmithKline
interim dividend at 33%
31 July 2002
|
|
|
Nicholas
Piramal net profit at Rs 311 million
19 July 2002
|
|
|
Nicholas Piramal to focus on mega brands
18 June 2002
|
|
|
NPIL ropes in McKinsey for total integration
27 May 2002
|
|
|
GlaxoSmithkline
to launch new products
12 March 2002
|
|
|
Nicholas Piramal''s new business strategy
04 March 2002
|
|
|
Pharma
companies in talks with MIDC
13 December 2001
|
|
|
Nicholas Piramal to focus on biotech
13 November 2001
|
|
|
Nicholas
Piramal-Rhone merger over
10 October 2001
|
|
|
Nicholas Piramal to launch drug
for malaria
19 February 2000
|
|
|
About osteoarthritis
21 January 2000
|
|
|
Piramal drug for osteoarthritis
21 January 2000
|
|
|
Nicholas Piramal India
Ltd.
15 December 1999
|
|
|
The
corporate retailers
01 December 1999
|
|
|
Nicholas Piramal will gain from
vitamin A price hike
10 November 1999
|
|
|
Vitamin
A manufacturing process
10 November 1999
|
|
|
Novartis, Nicholas to buy
Hoechst units
16 October 1999
|
|
|
Piramal-BUPA for one-stop
healthcare
15 October 1999
|
|
|
Norton
Healthcare ties up with Nicholas Piramal, RPG Life Sciences
06 August 1999
|
|
|
Nicholas
Piramal buys four Eli Lilly brands
22 July 1999
|
|
|
Hoechst, Nicholas Piramal to
co-market two products
01 July 1999
|
|
|
At the Crossroads of
''shoppertainment''
24 June 1999
|
|
|
Boots to sell Piramal ayurvedic
products in Europe
12 May 1999
|
|
|
Nicholas Piramal plans separate
IT business
11 May 1999
|
